Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62013CB0669

    Case C-669/13 P: Order of the Court of 21 October 2014 — Mundipharma GmbH v Office for Harmonisation in the Internal Market (Trade Marks and Designs), AFT Pharmaceuticals Ltd (Appeal — Community trade mark — Regulation (EC) No 40/94 — Application for registration of word mark Maxigesic — Opposition of the proprietor of the earlier word mark OXYGESIC — Refusal of registration)

    OJ C 16, 19.1.2015, p. 12–12 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    19.1.2015   

    EN

    Official Journal of the European Union

    C 16/12


    Order of the Court of 21 October 2014 — Mundipharma GmbH v Office for Harmonisation in the Internal Market (Trade Marks and Designs), AFT Pharmaceuticals Ltd

    (Case C-669/13 P) (1)

    (Appeal - Community trade mark - Regulation (EC) No 40/94 - Application for registration of word mark Maxigesic - Opposition of the proprietor of the earlier word mark OXYGESIC - Refusal of registration)

    (2015/C 016/17)

    Language of the case: German

    Parties

    Appellant: Mundipharma GmbH (represented by: F. Nielsen, Rechtsanwalt)

    Other parties to the proceedings: Office for the Harminisation in the Internal Market (Trade Marks and Designs) (represented by: D. Walicka, Agent), AFT Pharmaceuticals Ltd (represented by: N. Nentwig, Rechtsanwalt)

    Operative part of the order

    1.

    The appeal is dismissed.

    2.

    Mundipharma GmbH is ordered to pay the costs.


    (1)  OJ C 85, 22.3.2014.


    Top